Has built many patient programs and over 8 integrated software platforms to help blood cancer patients learn more about their disease and better navigate their disease. Interviewed Dr. Berenson on phase 1 data and others.
Outcomes of Triple Class Refractory Multiple Myeloma Patients | James Berenson, MD | ASH 2023 Video
Medical Writing Bias in Myeloma Clinical Research | James Berenson, MD | ASH 2023 Video
Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023 Video
